BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15691609)

  • 1. Report on the fifth annual Laragh conference: Interaction of the angiotensin converting enzyme (ACE) with the renin-angiotensin system, the kinin system and beyond.
    Gavras H
    Am J Hypertens; 2005 Jan; 18(1):1-2. PubMed ID: 15691609
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors].
    Linz W; Busch AE
    Pharm Unserer Zeit; 2003; 32(1):18-22. PubMed ID: 12577756
    [No Abstract]   [Full Text] [Related]  

  • 3. STRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.
    Manoharan S; Shuib AS; Abdullah N
    Afr J Tradit Complement Altern Med; 2017; 14(2):383-406. PubMed ID: 28573254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
    Tschöpe C; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions of vasoactive systems in cardiovascular damage.
    Bader M
    J Cardiovasc Pharmacol; 2001 Nov; 38 Suppl 2():S7-9. PubMed ID: 11811382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical insights into the beneficial and protective actions of the kallikrein-kinin system.
    Regoli D; Gobeil F
    Vascul Pharmacol; 2015 Jan; 64():1-10. PubMed ID: 25579779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.
    Regoli D; Gobeil F
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1117-1124. PubMed ID: 28384411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The long-term effects of a new converting enzyme inhibitor, delapril hydrochloride, on renal function, renin-angiotensin-aldosterone system and kallikrein-kinin prostaglandin system in hypertensive patients].
    Nishiyama K; Igari T; Nanba S; Ishii M
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):801-7. PubMed ID: 2273596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic actions of ACE inhibitors: a significant plus beyond antihypertensive therapeutic effects.
    Dézsi L
    Cardiovasc Res; 2000 Sep; 47(4):642-4. PubMed ID: 10974213
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
    Waeber B; Nussberger J; Brunner HR
    Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system and its blockers.
    Igić R; Škrbić R
    Srp Arh Celok Lek; 2014; 142(11-12):756-63. PubMed ID: 25731011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Renin-Angiotensin System, Not the Kinin-Kallikrein System, Affects Post-Exercise Proteinuria.
    Koçer G; Basralı F; Kuru O; Şentürk ÜK
    Nephron; 2018; 139(4):299-304. PubMed ID: 29772567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging concepts about the renin angiotensin system: present and future clinical applications.
    McLigeyo SO
    East Afr Med J; 1996 Sep; 73(9):607-10. PubMed ID: 8991244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain renin-angiotensin system modifies the blood pressure response to intracerebroventricular cadmium in rats.
    Varoni MV; Palomba D; Macciotta NP; Antuofermo E; Deiana G; Baralla E; Anania V; Demontis MP
    Drug Chem Toxicol; 2010 Jul; 33(3):302-9. PubMed ID: 20429803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly recognized physiologic and pathophysiologic actions of the angiotensin-converting enzyme.
    Fuchs S; Frenzel K; Xiao HD; Adams JW; Zhao H; Keshelava G; Teng L; Bernstein KE
    Curr Hypertens Rep; 2004 Apr; 6(2):124-8. PubMed ID: 15010016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.